These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 35131990)

  • 41. Budesonide/formoterol maintenance and reliever therapy: a new treatment approach for adult patients with asthma.
    Buhl R; Vogelmeier C
    Curr Med Res Opin; 2007 Aug; 23(8):1867-78. PubMed ID: 17605896
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Is the SMART approach better than other treatment approaches for prevention of asthma exacerbations? A meta-analysis.
    Agarwal R; Khan A; Aggarwal AN; Gupta D
    Monaldi Arch Chest Dis; 2009 Dec; 71(4):161-9. PubMed ID: 20440920
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Budesonide/formoterol for maintenance and reliever therapy of asthma: a meta analysis of randomised controlled trials.
    Edwards SJ; von Maltzahn R; Naya IP; Harrison T
    Int J Clin Pract; 2010 Apr; 64(5):619-27. PubMed ID: 20456215
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Towards the Grade of Recommendations, Assessment, Development and Evaluation system: methods and results of budesonide/formoterol maintenance and reliever therapy research.
    Braido F; Baiardini I; Compalati E; Bordo A; Canonica GW
    Curr Opin Allergy Clin Immunol; 2011 Aug; 11(4):361-74. PubMed ID: 21659859
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Budesonide/formoterol for maintenance and relief in uncontrolled asthma vs. high-dose salmeterol/fluticasone.
    Bousquet J; Boulet LP; Peters MJ; Magnussen H; Quiralte J; Martinez-Aguilar NE; Carlsheimer A
    Respir Med; 2007 Dec; 101(12):2437-46. PubMed ID: 17905575
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Combination formoterol and budesonide as maintenance and reliever therapy versus inhaled steroid maintenance for chronic asthma in adults and children.
    Cates CJ; Lasserson TJ
    Cochrane Database Syst Rev; 2009 Apr; (2):CD007313. PubMed ID: 19370682
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Global Initiative for Asthma Strategy 2021: Executive Summary and Rationale for Key Changes.
    Reddel HK; Bacharier LB; Bateman ED; Brightling CE; Brusselle GG; Buhl R; Cruz AA; Duijts L; Drazen JM; FitzGerald JM; Fleming LJ; Inoue H; Ko FW; Krishnan JA; Levy ML; Lin J; Mortimer K; Pitrez PM; Sheikh A; Yorgancioglu AA; Boulet LP
    J Allergy Clin Immunol Pract; 2022 Jan; 10(1S):S1-S18. PubMed ID: 34718211
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Treatment comparison of budesonide/formoterol with salmeterol/fluticasone propionate in adults aged > or =16 years with asthma: post hoc analysis of a randomized, double-blind study.
    Kuna P
    Clin Drug Investig; 2010; 30(9):565-79. PubMed ID: 20593912
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Maintenance plus reliever budesonide/formoterol compared with a higher maintenance dose of budesonide/formoterol plus formoterol as reliever in asthma: an efficacy and cost-effectiveness study.
    Lundborg M; Wille S; Bjermer L; Tilling B; Lundgren M; Telg G; Ekström T; Selroos O
    Curr Med Res Opin; 2006 May; 22(5):809-21. PubMed ID: 16709303
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Fixed or adjustable maintenance-dose budesonide/formoterol compared with fixed maintenance-dose salmeterol/fluticasone propionate in asthma patients aged >or=16 years: post hoc analysis of a randomized, double-blind/open-label extension, parallel-group study.
    Aalbers R
    Clin Drug Investig; 2010; 30(7):439-51. PubMed ID: 20528000
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Cost-utility of as-needed combination low-dose budesonide-formoterol in adolescents mild asthma.
    Buendía JA; Guerrero Patiño D; Talamoni HL
    Pediatr Pulmonol; 2021 Dec; 56(12):3699-3705. PubMed ID: 34473917
    [TBL] [Abstract][Full Text] [Related]  

  • 52. SMART for the treatment of asthma: A network meta-analysis of real-world evidence.
    Rogliani P; Beasley R; Cazzola M; Calzetta L
    Respir Med; 2021 Nov; 188():106611. PubMed ID: 34536699
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A comparison of budesonide/formoterol maintenance and reliever therapy vs. conventional best practice in asthma management.
    Louis R; Joos G; Michils A; Vandenhoven G
    Int J Clin Pract; 2009 Oct; 63(10):1479-88. PubMed ID: 19769705
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Single maintenance and reliever therapy (SMART) of asthma: a critical appraisal.
    Chapman KR; Barnes NC; Greening AP; Jones PW; Pedersen S
    Thorax; 2010 Aug; 65(8):747-52. PubMed ID: 20581409
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Asthma maintenance and reliever therapy: Should this be the standard of care?
    Cusack RP; Satia I; O'Byrne PM
    Ann Allergy Asthma Immunol; 2020 Aug; 125(2):150-155. PubMed ID: 32339657
    [TBL] [Abstract][Full Text] [Related]  

  • 56. 2020 NAEPP Guidelines Update and GINA 2021-Asthma Care Differences, Overlap, and Challenges.
    Chipps BE; Murphy KR; Oppenheimer J
    J Allergy Clin Immunol Pract; 2022 Jan; 10(1S):S19-S30. PubMed ID: 34718214
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Is the patient's baseline inhaled steroid dose a factor for choosing the budesonide/formoterol maintenance and reliever therapy regimen?
    Aubier M; Haughney J; Selroos O; van Schayck OC; Ekström T; Ostinelli J; Buhl R
    Ther Adv Respir Dis; 2011 Oct; 5(5):289-98. PubMed ID: 21586508
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Combination formoterol and inhaled steroid versus beta2-agonist as relief medication for chronic asthma in adults and children.
    Cates CJ; Lasserson TJ
    Cochrane Database Syst Rev; 2009 Jan; 2009(1):CD007085. PubMed ID: 19160317
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cost effectiveness of budesonide/formoterol for maintenance and reliever therapy versus salmeterol/fluticasone plus salbutamol in the treatment of asthma.
    Johansson G; Andreasson EB; Larsson PE; Vogelmeier CF
    Pharmacoeconomics; 2006; 24(7):695-708. PubMed ID: 16802845
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A randomized, open labeled, comparative study to assess the efficacy and safety of controller medications as add on to inhaled corticosteroid and long-acting β2 agonist in the treatment of moderate-to-severe persistent asthma.
    Patel YA; Patel P; Bavadia H; Dave J; Tripathi CB
    J Postgrad Med; 2010; 56(4):270-4. PubMed ID: 20935397
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.